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Abstract
Aim: To profile the full range of visual disorders from a large prospective observation 
study of stroke survivors referred by stroke multidisciplinary teams to orthoptic ser-
vices with suspected visual problems.
Methods: Multicenter prospective study undertaken in 20 acute Trust hospitals. 
Standardized	screening/referral	 forms	and	 investigation	forms	documented	data	on	
referral signs and symptoms plus type and extent of visual impairment.
Results:	Of	1,345	patients	referred	with	suspected	visual	 impairment,	915	were	re-
cruited	(59%	men;	mean	age	at	stroke	onset	69	years	[SD	14]).	 Initial	visual	assess-
ment was at median 22 days post stroke onset. Eight percent had normal visual 
assessment.	Of	92%	with	confirmed	visual	impairment,	24%	had	reduced	central	vis-
ual	acuity	<0.3	logMAR	and	13.5%	<0.5	logMAR.	Acquired	strabismus	was	noted	in	
16%	and	acquired	ocular	motility	disorders	 in	68%.	Peripheral	 visual	 field	 loss	was	
present	in	52%,	most	commonly	homonymous	hemianopia.	Fifteen	percent	had	visual	
inattention	and	4.6%	had	other	visual	perceptual	disorders.	Overall	84%	were	visually	
symptomatic with visual field loss the most common complaint followed by blurred 
vision,	 reading	difficulty,	and	diplopia.	Treatment	options	were	provided	 to	all	with	
confirmed visual impairment. Targeted advice was most commonly provided along 
with	refraction,	prisms,	and	occlusion.
Conclusions: There are a wide range of visual disorders that occur following stroke 
and,	frequently,	with	visual	symptoms.	There	are	equally	a	wide	variety	of	treatment	
options	available	for	these	individuals.	All	stroke	survivors	require	screening	for	visual	
impairment and warrant referral for specialist assessment and targeted treatment spe-
cific to the type of visual impairment.
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1  | INTRODUCTION
Poststroke	visual	impairment	occurs	frequently	with	an	estimated	
prevalence	of	65%	in	an	acute	stroke	population	(Hepworth	et	al.,	
2015).	Visual	 impairment	 in	 this	 population	 can	 be	 broadly	 cat-
egorized	 into	 four	 impaired	 visual	 functions	 of:	 reduced	 central	
vision,	 peripheral	visual	 field	 loss,	 eye	movement	disorders,	 and	
visual	 perceptual	 disorders	 (Jones	 &	 Shinton,	 2006).	 Each	 cate-
gory also comprises a range of visual deficits specific to that visual 
function.*The	members	of	the	VIS	writing	Group	are	listed	in	Appendix.
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Many visual impairments cause visual symptoms with stroke survi-
vors aware of blurred/altered vision or jumbled/double images. These 
visual symptoms cause impact to general function and to daily life 
(Hepworth	&	Rowe,	2016).	However,	a	wide	variety	of	interventions	
are	available	to	aid	and/or	ameliorate	these	symptoms	(Pollock	et	al.,	
2011a,	2011b,	2012).
The purpose of this study was to profile the full range of visual 
disorders	from	a	large,	prospective,	observation	cohort	study	of	stroke	
survivors	with	suspected	visual	impairment,	referred	by	stroke	multi-
disciplinary teams to orthoptic services.
2  | METHODS
2.1 | Study design and population
This prospective multicenter observational case cohort study com-
prised	 local	 orthoptic	 principal	 investigators	 from	 20	 UK	 hospital	
trusts responsible for assessing stroke patients and collecting patient 
data.	Orthoptic	services	for	stroke	units	 in	the	UK	provide	compre-
hensive visual assessment at the bedside and typically initiate man-
agement options at this acute stage. Review visits continue on the 
stroke	 unit	 as	 needed	 and,	 subsequently,	 in	 out-	patient	 eye	 clinics.	
The	data	were	collated	centrally	at	 the	University	of	Liverpool.	The	
study had multicenter ethical approval via the National Research 
Ethics	Service	(06/Q0904/5)	and	was	undertaken	in	accordance	with	
the	Tenets	of	Helsinki.
The target population was stroke patients suspected of having a 
visual	 difficulty.	 Referrals	 could	 be	made	 from	 in-	patient	wards,	 re-
habilitation	units,	community	services,	or	out-	patient	clinics.	Patients	
were	given	an	information	sheet	and	recruited	after	informed,	written	
consent. Patients were excluded if they were unable to consent due to 
cognitive	impairment,	unwilling	to	consent,	if	their	diagnosis	was	that	
of transient ischemic attack or if they were discharged without vision 
assessment.
2.2 | Measures
Patients with suspected visual difficulty were identified using a screen-
ing	form	(Figure	1:	SPSS:	RRID:	SCR_002865).	Subsequently	this	was	
used	as	the	referral	form	to	the	Orthoptic	service.	A	standardized	in-
vestigation sheet was used for the eye assessment consisting of iden-
tification	of	known	preexistent	ocular	pathology,	symptoms	and	signs,	
investigation	 of	 visual	 field,	 ocular	motility,	 and	 perceptual	 aspects	
(Rowe,	2011).	Visual	fields	were	assessed	qualitatively	by	traditional	
confrontation	 methods	 or	 quantitatively	 by	 Humphrey	 (Humphrey	
systems,	Dublin,	CA,	USA)	automated	central	and/or	peripheral	static	
perimetry	or	Goldmann/Octopus	(Haag	Streit	Int,	Switzerland)	kinetic	
perimetry.
Visual	acuity	was	assessed	uniocularly	at	near	and	distance	 fix-
ation	 with	 Snellen	 or	 logMAR	 acuity	 tests.	 Low	 visual	 acuity	 was	
considered in two categories. The first defined low visual acuity as 
less	 than	best	corrected	6/12	Snellens	acuity	or	0.3	logMAR	 in	ac-
cordance	with	UK	driving	standards.	The	second	defined	 low	visual	
acuity	as	less	than	6/18	Snellens	acuity	or	0.5	logMAR	and	equal	or	
better	 than	3/60	Snellens	acuity	as	per	World	Health	Organisation	
(WHO)	guidelines.
Assessment	 of	 ocular	 alignment	 and	motility	 consisted	 of	 cover	
test,	evaluation	of	saccadic,	smooth	pursuit	and	vergence	eye	move-
ments,	 retinal	 correspondence	 (Bagolini	 glasses),	 fusional	 vergence	
(20D	or	fusional	range),	stereopsis	(Frisby	near	test),	prism	cover	test,	
and lid and pupil function.
Perceptual	deficits	were	recorded	after	questioning	of	the	patient	
and/or carers and relatives. Inattention was assessed by means of a 
combination	 of	 assessments	 including	 line	 bisection,	 Albert’s	 test,	
cancellation	 tests,	 and	 memory	 tests	 using	 verbal	 description	 and	
drawing.	Alexia	was	diagnosed	where	patients	described	an	 inability	
to	read	(despite	being	able	to	see	the	text)	because	of	being	unable	to	
decipher the words or their meaning or being unable to make sense 
of the text.
Quality	of	life	was	undertaken	using	the	Activities	of	Daily	Living	
Dependent	 on	 Vision	 (ADLDV)	 questionnaire.	 This	 consists	 of	 22	
questions	related	to	vision	including	visual	recognition,	personal	care	
and	hygiene,	mobility,	and	reading.	It	uses	a	Likert	scale	of	1–4	indicat-
ing	the	individual	cannot	see	to	do	through	to	having	no	difficulty.	A	
full	“normal”	score	is	88.
Stroke	 details	were	 recorded	 from	 patient	 notes	 accounting	 for	
stroke	 laterality,	 type,	 and	 area	 involved.	 Ocular	 treatment	 details	
were recorded along with outcome. Reasons for nonattendance at 
review	appointments	included	death,	a	move	out	of	area,	lost	to	fol-
low-	up,	follow-	up	unwanted,	or	unknown.
2.3 | Data analysis
Results	were	inputted	to	the	statistical	package	SPSS	version	22	(IBM	
SPSS	Statistics,	USA).	Pearson	chi	squared	test	(x2)	was	undertaken	to	
analyze	cross	tabulations	of	results	for	visual	field	loss	and	outcome	of	
follow-	up	versus	factors	such	as	age,	presence	of	other	visual	impair-
ment,	laterality,	and	area	of	stroke	and	recovery.	A	t test was used to 
analyze	differences	between	similar	measurements	with	normal	distri-
butions,	for	example,	strabismus.
3  | RESULTS
3.1 | General demographics
One thousand three hundred and forty- five patients were referred for 
visual	assessment	for	this	study.	All	were	suspected	of	having	visual	
problems.	Nine	hundred	and	fifteen	patients	were	recruited	and	430	
patients were excluded. Reasons for exclusion included inability/un-
willing	to	provide	informed,	written	consent	as	required	of	the	ethical	
approval for this study (n	=	259),	 patients	were	 discharged	 prior	 to	
receiving visual assessment (n	=	52),	diagnosis	was	changed	to	tran-
sient ischemic attack or other pathology (n	=	54),	patients	died	prior	
to visual assessment (n	=	26),	 or	 patients	 failed	 to	 attend	 for	 visual	
assessment (n	=	4).	It	was	not	possible	to	obtain	full	visual	information	
on these excluded patients.
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Of	 915	 patients	 recruited,	 59%	 (n	=	540)	 were	 men	 and	 41%	
(n	=	375)	women.	Mean	 age	 at	 onset	 of	 stroke	was	69	years	 (range	
1–94:	 SD	 14	years).	 One	 patient	 was	 aged	 1	year	 and	 the	 range	
thereafter	was	19–94	years.	The	median	age	at	onset	of	stroke	was	
71 years.
Median duration from onset of stroke to initial baseline eye exam-
ination	was	22	days	 (0–2543	days),	 the	mean	of	 40.84	 (SD	141.28)	
days being skewed by three outliers who were referred a number of 
years	after	the	stroke	onset.	Stroke	lesion	was	right	sided	in	448	pa-
tients	(49%,	i.e.,	right	sided	brain),	left	sided	in	348	(38%),	and	bilateral	
in	119	 (13%).	 Infarcts	accounted	for	773	cases	 (84.5%)	with	 the	re-
mainder due to hemorrhage.
Overall,	8%	(n	=	72)	had	normal	visual	assessment.	Of	those	for-
mally	 diagnosed	with	visual	 impairment,	 45.5%	 (n	=	415)	 had	 solely	
one	form	of	visual	impairment:	17%	(n	=	155)	had	visual	field	loss,	20%	
(n	=	181)	had	eye	movement	abnormalities,	2%	(n	=	17)	had	visual	per-
ceptual	difficulties,	and	7%	(n	=	62)	had	 low	central	vision—whereas	
46.5%	(n	=	423)	had	multiple	visual	impairments.
3.2 | Central vision
Median	 visual	 acuity	 for	 each	 eye	was	0.2	logMAR	with	 a	mean	of	
0.26	(SD	0.39,	range	−0.2–2.5).	About	32%	(n	=	296)	had	visual	acuity	
of	0.0	logMAR	(6/6	Snellen	equivalent)	or	better,	76%	had	visual	acu-
ity	of	0.3	logMAR	(6/12	Snellen)	or	better	 (n	=	698),	and	86.5%	had	
visual	acuity	of	0.5	logMAR	(6/18	Snellen)	or	better	(n	=	792).	Three	
quarters	of	the	cohort	required	glasses	(75.6%,	n	=	692),	5%	had	pre-
existent	strabismus	and/or	amblyopia	and	27.4%	had	coexistent	ocu-
lar	pathology;	typically	glaucoma,	age-	related	macular	degeneration,	
cataract,	and	diabetic	retinopathy	(Table	1).
F IGURE  1 Screening/Referral	form	for	
Orthoptic examination
PATIENT DETAILS PRIORITY*
Name: DOB: Soon Urgent
Address: Insert identity label
Telephone: Current ward / department:
Hospital number: Male / female:
DETAILS OF STROKE
Date of onset: Diagnosis:
MRI/CT date and report:
OCULAR SYMPTOMS Does the patient complain of:
Diplopia Blurred/reduced 
vision
Reading 
difficulties
Visual field loss 
or inattention
Other (specify)
OCULAR SIGNS Are any of the following evident:
Squint Defective eye 
movements
Nystagmus Ptosis Abnormal 
pupils
Suspected vision 
difficulty
OCULAR HISTORY
Are there any known pre-existing ocular conditions, e.g. cataract, retinopathy, macular 
degeneration?
COGNITION
Comment of the patient’s cognitive / functional / physical ability, i.e. presence of agnosia, 
alexia, aphasia, hemiplegia, etc.
MEDICATIONS:
EXPECTED DATE OF DISCHARGE (IF IN-PATIENT):
SIGNED: DATE:
PRINT NAME: DESIGNATION:
4 of 8  |     ROWE
3.3 | Ocular alignment and movement
Manifest	strabismus	was	noted	in	18.5%	(n	=	169)	patients	of	which	
3%	was	long-	standing	prior	to	the	stroke	onset	(Table	2A).	Acquired	
constant	exotropia	occurred	most	frequently,	p = .001.
Ocular	motility	abnormalities	were	documented	in	68%	(n	=	622)	
patients	 (Table	2B);	 most	 frequently	 saccadic	 dysmetria	 (30.4%,	
n	=	278),	 gaze	 defects	 (22.6%,	 n	=	207),	 and	 cranial	 nerve	 palsies	
(9.7%,	n	=	89).	A	variety	of	nystagmus	types	were	recorded	in	12.2%	
(n	=	112)	with	 the	most	 common	 type	being	pathological	 end-	point	
nystagmus	(Table	2C).
Normal	 convergence	 near	 point	 of	 6	cm	was	 reported	 in	 nearly	
39%	 of	 patients	 (n	=	354).	 Reduced	 near	 point	 of	 convergence	 less	
than	 8	cm	was	 recorded	 in	 nearly	 38%	 (n	=	345)	 and	 for	 less	 than	
10	cm	in	26.7%	(n	=	235).
3.4 | Lid and pupil function
Normal	 lid	 function	was	 evident	 in	 85.9%	 (n	=	786).	 The	 remainder	
had	unilateral	or	bilateral	ptosis	or	lid	retraction,	with	unilateral	ptosis	
being	most	common	(Table	3A).	Normal	pupil	function	was	evident	in	
TABLE  2 Eye movement disorders
A Strabismus types
Exotropia Esotropia Hypertropia Hypotropia Eso and hypotropia Exo and hypotropia Skew	deviation
68 44 16 12 1 22 6
B Ocular motility disorders
III nerve palsy IV	nerve	palsy VI	nerve	palsy Ophthalmoplegia Impaired	gaze	
holding
Patients with sole motility 
disorder
9 8 24 3 37
Patients with multiple motility 
disorders
11 4 28 0 9
Complete	gaze	
palsy
Horizontal	gaze	
palsy
Vertical	gaze	palsy Dorsal midbrain 
syndrome
INO/one and a 
half syndrome
Patients with sole motility 
disorder
15 0 0 5 9
Patients with multiple motility 
disorders
8 16 17 3 11
Saccadic	palsy Saccadic	
dysmetria
Smooth	pursuit	palsy Impaired depression Impaired 
elevation
Patients with sole motility 
disorder
17 206 18 3 0
Patients with multiple motility 
disorders
11 72 28 3 42
C Nystagmus types
Upbeat Pendular Horizontal Downbeat Rotary Multivector
11 1 12 7 6 7
Pathological end- point Abducting Retraction Gaze	evoked Latent Idiopathic
31 9 8 17 1 2
Numbers of patients.
TABLE  1 Types of coexistent ocular pathology
Number of 
patients Cataract Retinopathy
Age- related 
macular 
degenera-
tion Glaucoma Pupil anomaly Color defect Artificial eye Corneal anomaly
Patients with 
sole ocular 
pathology
26 6 2 19 0 0 0 0
Patients with 
multiple ocular 
pathologies
102 38 20 22 3 2 2 2
A	further	seven	patients	were	registered	partially	sighted.
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90.8%	(n	=	831)	with	the	remainder	having	varied	forms	of	dilated	or	
miosed	pupils	(Table	3B).	Relative	afferent	pupillary	defect	and	aniso-
coria were the most common forms.
3.5 | Visual field loss and visual perception
Over	half	(52.3%,	n	=	479)	of	patients	had	visual	field	loss	(Table	4).	The	
most common type of visual field loss was found to be complete (n	=	259)	
and partial (n	=	79)	homonymous	hemianopia	and	occurring	significantly	
more	 frequently	 to	 the	 left	 side	 than	 to	 the	 right	 side	 or	 bilaterally,	
p = .001 (t	test).	Other	types	included	superior	or	inferior	quadrantano-
pia (n	=	73),	constricted	visual	fields	(n	=	44),	scotomas	(n	=	5),	temporal	
crescent defect (n	=	1),	and	bilateral	hemianopia	(cortical	blindness:	n	=	1).
Visual	 inattention	 was	 noted	 in	 15%	 of	 the	 cohort	 (n	=	137)	
whereas	other	visual	perceptual	deficits	such	as	visual	agnosia,	corti-
cal	color	visual	or	depth	impairment,	and	acquired	alexia	were	noted	
in	4.6%.
3.6 | Symptoms
Visual	symptoms	(Table	5)	were	reported	by	84%	of	patients	(n	=	766)	
either	as	a	sole	symptom	 (56%)	or	combined	as	 two	or	more	visual	
symptoms	 (28%).	 Visual	 field	 loss	was	 the	most	 common	 symptom	
(45.6%)	followed	by	blurred	vision	(31.2%),	reading	difficulty	(19.6%),	
and	 diplopia	 (17.3%).	 Visual	 field	 loss	was	 typically	 reported	 in	 the	
presence	of	visual	field	loss,	diplopia	was	typical	for	ocular	alignment	
and/or	motility	 disorders,	 whereas	 blurred	 vision	 and	 reading	 diffi-
culty were nonspecific symptoms of various ocular diagnoses. Fifty 
patients had a normal visual examination despite having reported 
visual symptoms.
3.7 | Management
Treatment options were offered to all patients with visual impair-
ment	 (92%:	 Table	6).	 Referral	 for	 new	 or	 updated	 refraction	 was	
most	commonly	provided	(29.3%,	n	=	247)	followed	by	prisms	(12%,	
n	=	101),	 occlusion	 (7.8%,	 n	=	66),	 typoscopes	 (8.9%,	 n	=	75),	 and	
low	vision	aids	(3.8%,	n	=	32).	Advice	was	offered	to	almost	all	pa-
tients	(99%)	and	consisted	of	information	about	eye	and	head	scan-
ning	 training,	 reading	 strategies,	 appropriate	 lighting,	 visual	 field	
awareness,	visual	 inattention	awareness,	and	use	of	compensatory	
head posture.
TABLE  3 Lid	and	pupil	disorders
A Lid function disorders
Unilateral 
ptosis
Bilateral	
ptosis
Unilateral lid 
retraction
Bilateral	lid	
retraction
Senile	
ptosis
80 8 5 5 5
B Pupil disorders
Relative 
afferent 
pupillary 
defect
Light-	near	
dissociation
Anisocoria Middilated 
pupils
Miosed 
pupils
14 3 15 6 8
Sluggish	
pupils
Horner’s	
syndrome
Adie’s	pupil Coloboma
4 5 1 1
Numbers of patients.
TABLE  4 Types of visual field loss
Complete 
homonymous 
hemianopia
Partial 
homonymous 
hemianopia
Macular sparing 
homonymous 
hemianopia
Superior 
quadrantanopia
Inferior  
quadrantanopia
Chequerboard 
quadrantanopia
Constricted 
visual fields
259 79 5 30 40 3 44
Scotoma Altitudinal Bilateral 
homonymous 
hemianopia
Spared 
temporal 
crescent
Homonymous hemianopia 
and contralateral 
quadrantanopia
Binasal hemianopia Unilateral blind 
eye
5 3 1 1 6 1 2
Numbers of patients.
TABLE  5 Visual	symptoms
Visual field 
loss
Blurred 
vision
Reading 
difficulty Diplopia
Visual 
hallucination Oscillopsia
Perceptual 
difficulties
Patients reporting one primary 
symptom
N	=	511/766	(56%)
227	(24.8%) 134	(14.6%) 39	(4.3%) 84	(9.2%) 13	(1.4%) 1	(0.1%) 13	(1.4%)
Patients reporting multiple symptoms 
N	=	255/766	(28%)
190	(20.8%) 152	(16.6%) 140	(15.3%) 74	(8.1%) 20	(2.2%) 6	(0.7%) 44	(4.8%)
Total reporting symptoms 
N	=	766/915	(84%)
45.6% 31.2% 19.6% 17.3% 3.6% 0.8% 6.2%
Perceptual	difficulties	inclusive	of:	depth	perception	difficulty,	alexia,	agraphia,	photophobia,	color	perception	difficulties.
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3.8 | Impact to activities of daily living
Activities	of	daily	 living	dependent	on	vision	were	assessed	 for	pa-
tients	with	and	without	visual	symptoms	(Figure	2).	There	was	no	sig-
nificant	difference	between	groups,	p	=	.447	(Pearson	x2	test).
4  | DISCUSSION
This study comprised a subpopulation of stroke survivors; those re-
ferred	with	suspected	visual	impairment.	A	high	percentage	of	stroke	
survivors	were	subsequently	confirmed	as	having	visual	impairment	
(92%).	Types	 of	visual	 impairment	 included	visual	 field	 loss,	 ocular	
motility	disorders,	reduced	central	visual	acuity,	and	visual	perceptual	
disorders.	Visual	 impairment	most	 likely	 to	be	new	and	due	 to	 the	
stroke	 included	 visual	 field	 loss,	 ocular	motility	 disorders,	 and	 vis-
ual perceptual disorders. Complete homonymous hemianopia was 
the most common form of visual field loss with partial hemianopia 
and	 quadrantanopia	 visual	 field	 defects	 also	 occurring	 frequently.	
Saccadic	 dysmetria	was	 the	most	 common	 form	 of	 ocular	motility	
disorder	with	other	 frequently	occurring	disorders	 including	cranial	
nerve	 palsy,	 gaze	 palsy,	 strabismus,	 reduced	 near	 point	 of	 conver-
gence,	and	nystagmus.	As	expected,	visual	inattention	was	the	most	
commonly	occurring	visual	perceptual	disorders	but,	in	addition,	pa-
tients were noted to report cortical impairment of color perception 
or	depth,	alexia,	and	visual	agnosia.	Fifty	 stroke	survivors	had	nor-
mal	visual	 assessment	 and	were	visually	 asymptomatic	 but,	 poten-
tially,	these	may	previously	have	been	visually	symptomatic	but	had	
TABLE  6 Treatment options across visual function categories
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recovery of their visual impairment by the time of undergoing visual 
assessment.
Reduced	visual	acuity	of	worse	than	0.3	logMAR	was	noted	in	24%	
of stroke survivors. Impaired central vision is often likely to precede a 
stroke and be due to coexistent ocular problems. For this cohort of 
stroke	survivors,	glasses	were	a	common	requirement	 for	near	and/
or distance vision and coexistent or childhood ocular problems were 
noted	in	about	one-	third	of	these	patients.	Similarly	the	finding	of	rela-
tive afferent pupillary defect and anisocoria were commonly related to 
ocular problems and less likely to be new onset related to stroke unlike 
pupil	conditions	such	as	Horner’s	syndrome	and	light-	near	dissociation	
which were stroke- related.
Diagnosis and confirmation of both new onset visual impairment 
and	 preexistent	 visual	 impairment	 are	 equally	 important;	 to	 ensure	
new onset visual impairment is accurately assessed and managed and 
to ensure that those with preexistent visual impairment continue with 
any	previously	ordered	management	program.	Maximizing	remaining	
visual function is essential to aid general rehabilitation.
Clearly,	focused	investigation	is	required	to	confirm	the	diagnosis	
of	many	of	 these	disorders,	particularly	 those	with	more	subtle	pre-
sentation	features.	Visual	symptoms	were	reported	overall	by	84%	of	
patients	 but	 of	 a	wide	variety	 as	 reported	previously	 (Rowe,	 2013).	
Notably,	of	16%	who	were	asymptomatic,	many	had	confirmed	visual	
impairment	 including	substantial	hemianopic	visual	field	 loss,	 limited	
eye	movements,	and	reduced	visual	acuity.	This	latter	group	raises	the	
question	 of	 how	many	 stroke	 survivors	with	visual	 impairment	may	
remain undetected where formal vision screening is not undertaken. 
This study only recruited those referred with suspected visual impair-
ment	and	used	a	screening/referral	 form	to	 facilitate	 this.	However,	
as	published	previously,	 issues	exist	with	 such	 screening	 forms	par-
ticularly where there is reliance on patient- reported visual symptoms 
to	aid	 identification	of	suspected	visual	 impairment	 (Rowe,	2011).	 It	
remains unknown how many patients with visual impairment were 
undetected because of patient failure to report visual symptoms ei-
ther	because	of	 communication,	 cognitive,	or	other	 failure	 to	notify	
staff/carers of their symptoms and visual difficulties. Only specialist 
widespread visual screening of all stroke survivors will aid capture of 
such cases.
Given	 that	 poststroke	 visual	 impairment	 is	 estimated	 at	 65%	
(Hepworth	et	al.,	 2015)	 and	 in	view	of	 the	confirmed	unmet	needs	
reported	 by	 stroke	 survivors	 with	 visual	 impairment	 (Rowe	 et	al.,	
2015)	there	 is	an	urgent	requirement	to	 implement	comprehensive,	
wide- spread screening of stroke survivors to ensure identification of 
their visual issues. National guidance exists for provision of specialist 
services on stroke units for poststroke visual impairment with ortho-
ptists being recommended as part of the core acute stroke unit team 
(British	Irish	Orthoptic	Society,	2016;	Intercollegiate	Stroke	Working	
Party,	2016);	services	that	are	proven	to	be	feasible	and	acceptable	
for delivery on acute stroke units and neuro- rehabilitation units and 
which	 are	 cost	 effective	 (Pollock,	 Hazelton,	 &	 Brady,	 2011;	 Rowe	
et	al.,	2016).	Recent	research	reports	vision	screening	to	be	achiev-
able at a median of 3 days post stroke with full visual examinations 
achieved	at	a	median	of	4	days	post	stroke	(Rowe,	Hepworth,	Hanna,	
&	Howard,	2016).
The impact of visual impairment is clear with considerable issues 
relating	to	driving,	activities	of	daily	living,	mobilization,	social	engage-
ment	among	others	(Hepworth	&	Rowe,	2016).	Given	the	high	rate	of	
visual	 symptoms	and	known	 impact,	 access	 to	appropriate	manage-
ment	options	at	the	early	acute	poststroke	stage	is	important.	A	wide	
variety	of	management	options	were	provided	in	this	study,	many	of	
which	are	evidence	based	as	to	their	efficacy	(Adler,	2002;	Carruthers,	
Kennedy,	&	Bagaric,	1990;	Firth	&	Whittle,	1994;	Pollock	et	al.,	2011,	
2011a,	2011b,	2012;	Thurtell	&	Leigh,	2010).	It	is	important	to	note	
that,	for	advice	on	compensatory	mechanisms,	these	are	frequently	of	
benefit to patients despite lacking an evidence base through case con-
trol	or	randomized	trials.	It	is	of	further	importance	to	recognize	these	
management	 options	 are	 not	 ‘one	 size	 fits	 all’	 but	 require	 targeting	
to the type of visual impairment and individual symptoms. Ensuring 
referral to specialist services will direct the stroke survivor to correct 
and	 appropriate	 treatment,	whilst	minimizing	 risks	 from	 inappropri-
ate	 therapies	 provided	by	 staff	 lacking	 the	 requisite	 training	 and/or	
knowledge.
5  | CONCLUSIONS
The	Vision	In	Stroke	study	 is,	to	our	knowledge,	the	first	 large-	scale	
observation study of poststroke visual impairment. In this population 
of	stroke	survivors	referred	with	suspected	visual	impairment,	preva-
lence	of	visual	impairment	was	92%.	There	are	a	wide	range	of	visual	
disorders	that	occur	following	stroke	and,	frequently,	give	rise	to	visual	
symptoms.	There	are	equally	a	wide	variety	of	treatment	options	avail-
able for these individuals. We recommend that all stroke survivors 
require	 screening	 for	visual	 impairment	 in	 the	early	days	poststroke	
onset and warrant referral for specialist assessment and targeted 
treatment specific to the type of visual impairment.
F IGURE  2 ADLDV	quality	of	life	scores
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